Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Furiex Pharmaceuticals Inc FURX

Healthcare Drug Manufacturers - Specialty & Generic

Recent & Breaking News (NDAQ:FURX)

Actavis Completes Acquisition of Furiex Pharmaceuticals

PR Newswire July 2, 2014

Furiex Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger

Business Wire July 1, 2014

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of Directors of Company in Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX

GlobeNewswire May 23, 2014

SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection with the Sale of Furiex Pharmaceuticals, Inc. to Forest Laboratories, Inc. and Royal Empress, Inc.

Business Wire May 22, 2014

SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of Furiex Pharmaceuticals, Inc. to Forest Laboratories, Inc. and Royal Empress, Inc. -- FURX

GlobeNewswire May 14, 2014

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of Directors of Company In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX

Business Wire May 13, 2014

Furiex Pharmaceuticals Reports First Quarter 2014 Financial Results

Business Wire May 7, 2014

SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Furiex Pharmaceuticals, Inc. in Connection with the Proposed Sale of the Company to Forest Laboratories, Inc.

Business Wire May 5, 2014

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of Directors of Company in Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX

GlobeNewswire May 5, 2014

INVESTOR ALERT - FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc.

Business Wire May 2, 2014

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Furiex Pharmaceuticals, Inc. Buyout

Business Wire May 1, 2014

INVESTOR ALERT - FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc. -- FURX

PR Newswire April 30, 2014

Ryan & Maniskas, LLP Announces Investigation of Furiex Pharmaceuticals, Inc.

PR Newswire April 29, 2014

INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX

PR Newswire April 29, 2014

Harwood Feffer LLP Announces Investigation of Furiex Pharmaceuticals, Inc.

PR Newswire April 28, 2014

FURIEX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Furiex Pharmaceuticals, Inc. (FURX) Over the Proposed Sale of the Company to Forest Laboratories, Inc.

Business Wire April 28, 2014

Acquisition of Furiex Pharmaceuticals, Inc. by Forest Laboratories, Inc. May Not Be in Shareholders' Best Interests

PR Newswire April 28, 2014

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Furiex Pharmaceuticals, Inc. Stockholders

Business Wire April 28, 2014

Morgan & Morgan Announces the Investigation of Furiex Pharmaceuticals, Inc. FURX

PR Newswire April 28, 2014

FURIEX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Furiex Pharmaceuticals

PR Newswire April 28, 2014